Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

tACS to Enhance Language Abilities

NCT: NCT06092814 · RECRUITING

NCT IDNCT06092814
StatusRECRUITING
Start Date2024-07-12
Completion2028-08-31
SponsorUniversity of Pennsylvania (OTHER)
First posted
Last updated

Brief Summary

The goal of this study is to see if transcranial alternating current stimulation (tACS) can be used to enhance language abilities in people with post-stroke aphasia. Participants will receive real and sham tACS in conjunction with various language tests. Researchers will compare the post-stroke aphasia group with aged matched controls to see if brain response to tACS differs between groups.

Frequently Asked Questions

What is tACS to Enhance Language Abilities?

tACS to Enhance Language Abilities is a clinical trial registered under NCT06092814. Current status: RECRUITING.

What is the status of NCT06092814?

The current status of NCT06092814 (tACS to Enhance Language Abilities) is: RECRUITING.

When did tACS to Enhance Language Abilities start?

tACS to Enhance Language Abilities started on 2024-07-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.